CPI Supports GlycoSeLect to Develop High Throughput Glycan Analysis Platform for Biotherapeutics
GlycoSeLect team is pleased to share the news that CPI used GSL RPL technology and ForteBio biosensor technology to create a rapid and high throughput innovative glycan analysis platform.
News October 2017: GlycoSeLect Completes 450K Seed Funding Round More >>
News Jan 2017: Silicon Republic - Innovation: GlycoSeLect Listed as One of "10 Marvellous Medtec Start-Ups You Need to Know" More >>
Latest News: October 24th 2017
RPLs are enhanced glycoselective bioaffinity proteins that enable efficient detection, analysis and selective isolation of glycosylated biomolecules. Applications
GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
Recombinant Prokaryotic Lectins